Lallemand Health Solutions has announced that its clinically studied gut-brain-skin axis formula, Cerebiome, has received a new authorised health claim in Canada:
"This approval by the Canadian authorities recognises Cerebiome for its benefits on skin health. It marks a significant step forward in our mission to deliver science-backed probiotic solutions. It adds another proof of efficacy aimed at improving consumer health in a holistic way.", said Solange Henoud, Vice President Regulatory and Compliance at Lallemand Health Solutions.
Elodie Aragon, Product Manager, added: "Cerebiome is redefining beauty and wellness by addressing gut-brain and skin health together. This recognition validates our commitment to innovation and the growing demand for nutricosmetic solutions."
Probiotics are increasingly recognized for their role in overall well-being and skin health, with 66% of consumers acknowledging this link. The nutricosmetics market reflects this growing interest, valued at $8.09 billion in 2023 and projected to reach $11.91 billion by 2028, at a CAGR of 8%.
